Aligos therapeutics to present data on pan-coronavirus protease inhibitors for the treatment of covid-19 at cambridge healthtech institute's 20th annual discovery on target conference, to be held october 17-20, 2022 in boston, ma

Aligos' pan-coronavirus inhibitor, alg-097558, is on track to begin first clinical studies in 1h 2023 aligos' pan-coronavirus inhibitor, alg-097558, is on track to begin first clinical studies in 1h 2023

ALGS Ratings Summary

ALGS Quant Ranking